AU2008318196B2 - Medium-chain length fatty acids and glycerides as nephroprotection agents - Google Patents

Medium-chain length fatty acids and glycerides as nephroprotection agents Download PDF

Info

Publication number
AU2008318196B2
AU2008318196B2 AU2008318196A AU2008318196A AU2008318196B2 AU 2008318196 B2 AU2008318196 B2 AU 2008318196B2 AU 2008318196 A AU2008318196 A AU 2008318196A AU 2008318196 A AU2008318196 A AU 2008318196A AU 2008318196 B2 AU2008318196 B2 AU 2008318196B2
Authority
AU
Australia
Prior art keywords
patient
formula
administration
kidney
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008318196A
Other languages
English (en)
Other versions
AU2008318196A1 (en
Inventor
Lyne Gagnon
Mouna Lagraoui
Francois Leblond
Vincent Pichette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liminal Biosciences Ltd
Original Assignee
Prometic Pharma SMT Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Pharma SMT Ltd filed Critical Prometic Pharma SMT Ltd
Publication of AU2008318196A1 publication Critical patent/AU2008318196A1/en
Application granted granted Critical
Publication of AU2008318196B2 publication Critical patent/AU2008318196B2/en
Assigned to PROMETIC PHARMA SMT LIMITED reassignment PROMETIC PHARMA SMT LIMITED Request for Assignment Assignors: PROMETIC BIOSCIENCES INC.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2008318196A 2007-11-02 2008-11-03 Medium-chain length fatty acids and glycerides as nephroprotection agents Ceased AU2008318196B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98509407P 2007-11-02 2007-11-02
US60/985.094 2007-11-02
PCT/CA2008/001930 WO2009055933A1 (en) 2007-11-02 2008-11-03 Medium-chain length fatty acids and glycerides as nephroprotection agents

Publications (2)

Publication Number Publication Date
AU2008318196A1 AU2008318196A1 (en) 2009-05-07
AU2008318196B2 true AU2008318196B2 (en) 2014-04-10

Family

ID=40590499

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008318196A Ceased AU2008318196B2 (en) 2007-11-02 2008-11-03 Medium-chain length fatty acids and glycerides as nephroprotection agents

Country Status (19)

Country Link
US (1) US9532962B2 (enExample)
EP (1) EP2299998B1 (enExample)
JP (1) JP5575655B2 (enExample)
KR (1) KR101601987B1 (enExample)
CN (1) CN101878028A (enExample)
AU (1) AU2008318196B2 (enExample)
BR (1) BRPI0818310A8 (enExample)
CA (1) CA2704286C (enExample)
DK (1) DK2299998T3 (enExample)
ES (1) ES2664594T3 (enExample)
IL (1) IL205362A (enExample)
MX (1) MX338513B (enExample)
MY (1) MY151439A (enExample)
NO (1) NO2299998T3 (enExample)
NZ (1) NZ584981A (enExample)
PT (1) PT2299998T (enExample)
RU (1) RU2519215C2 (enExample)
WO (1) WO2009055933A1 (enExample)
ZA (1) ZA201003030B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011011757A (es) 2009-05-04 2012-01-25 Prometic Biosciences Inc Compuestos aromaticos substituidos y usos farmaceuticos.
JP5706142B2 (ja) * 2010-04-28 2015-04-22 株式会社ファンケル フユボダイジュ花のエタノール抽出物を有効成分とする血中グルコース低下剤、内臓脂肪蓄積抑制剤、ｔｇ低下剤、糞中脂肪排泄促進剤
EA035494B1 (ru) * 2010-10-27 2020-06-25 Прометик Фарма Смт Лимитед Способ и применение композиции для ингибирования миграции клеток опухоли и образования метастазов
CN107028926A (zh) 2011-08-26 2017-08-11 国立大学法人大阪大学 糖尿病性心血管并发症的预防/治疗剂
KR20130023583A (ko) * 2011-08-29 2013-03-08 아주대학교산학협력단 파골세포 형성 억제 효과가 있는 카프르산 및 이를 포함하는 약학적 조성물
US10130603B2 (en) 2013-11-05 2018-11-20 Colgate-Palmolive Company Methods and compositions for improving kidney function
WO2017074266A1 (en) * 2015-10-30 2017-05-04 National University Of Singapore Androgen biosynthesis inhibitor
CN105559071A (zh) * 2016-01-12 2016-05-11 刘保惠 一种适用于肾病的特殊医学用途配方食品及其制备方法
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
WO2017211274A1 (en) 2016-06-08 2017-12-14 Dong Yuhong Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
US20210128694A1 (en) * 2016-12-21 2021-05-06 Prometic Pharma Smt Limited Methods and compositions for preventing or minimizing epithelial-mesenchymal transition
WO2019082912A1 (ja) * 2017-10-27 2019-05-02 学校法人北里研究所 慢性腎臓病の予防又は治療剤
US20190240180A1 (en) * 2018-02-08 2019-08-08 Nestec Sa Mct-based nutrition blend for providing health benefits in companion animals
MX2021003750A (es) 2018-10-11 2021-06-15 Basf As Compuestos aromaticos y usos farmaceuticos de los mismos.
CN109602012A (zh) * 2018-12-11 2019-04-12 李卫平 一种功能性低蛋白能量米及其制备方法
CN111184728B (zh) * 2020-02-20 2023-04-04 上海市儿童医院 海藻糖在肾病综合征中的应用
CN119421643A (zh) * 2022-06-15 2025-02-11 希尔氏宠物营养品公司 宠物食品组合物
JP2024176004A (ja) * 2023-06-07 2024-12-19 リファインホールディングス株式会社 小胞体ストレス抑制剤、慢性腎臓病疾患予防改善剤および食品
CN118592613B (zh) * 2024-08-05 2025-01-07 杭州康源食品科技有限公司 中链脂肪酸混合结构脂在改善膳食诱导的糖脂代谢紊乱中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083120A2 (en) * 2001-04-18 2002-10-24 Prometic Biosciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
WO2004069237A1 (en) * 2003-02-07 2004-08-19 Prometic Biosciences Inc. Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602040A (en) 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4737384A (en) * 1985-11-01 1988-04-12 Allied Corporation Deposition of thin films using supercritical fluids
CA2107581A1 (en) 1992-02-07 1993-08-08 Kiyoshi Sugiyama Side-effect alleviant
US6689700B1 (en) * 1999-11-02 2004-02-10 University Of Massachusetts Chemical fluid deposition method for the formation of metal and metal alloy films on patterned and unpatterned substrates
ES2234877T5 (es) 2000-06-20 2010-10-18 Nutrition Sciences Acidos grasos de cadena media utilizables como agentes antimicrobianos.
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
CN1827766B (zh) 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
RU2213570C2 (ru) * 2001-08-22 2003-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО ИЗ ЛИСТЬЕВ ЛИПЫ Folia Tilia И СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТИВНЫХ ВЕЩЕСТВ
US7030168B2 (en) * 2001-12-31 2006-04-18 Advanced Technology Materials, Inc. Supercritical fluid-assisted deposition of materials on semiconductor substrates
US20040052836A1 (en) 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
KR101120813B1 (ko) 2003-07-25 2012-03-23 프로메틱 바이오사이언시즈 인코포레이티드 중-쇄 지방산 금속염의 제조 방법
WO2007117272A2 (en) 2005-09-30 2007-10-18 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Methods for treatment of hemorrhagic shock and related disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083120A2 (en) * 2001-04-18 2002-10-24 Prometic Biosciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
WO2004069237A1 (en) * 2003-02-07 2004-08-19 Prometic Biosciences Inc. Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Research in Experimental Medicine, Vol. 199, No. 4, February 2000, pages 195-206 *

Also Published As

Publication number Publication date
NO2299998T3 (enExample) 2018-06-02
MY151439A (en) 2014-05-30
RU2519215C2 (ru) 2014-06-10
KR101601987B1 (ko) 2016-03-09
MX2010004856A (es) 2010-06-30
JP2011502174A (ja) 2011-01-20
CA2704286A1 (en) 2009-05-07
AU2008318196A1 (en) 2009-05-07
IL205362A (en) 2015-01-29
US20100286269A1 (en) 2010-11-11
ES2664594T3 (es) 2018-04-20
US9532962B2 (en) 2017-01-03
EP2299998B1 (en) 2018-01-03
MX338513B (es) 2016-04-20
JP5575655B2 (ja) 2014-08-20
CA2704286C (en) 2016-08-23
EP2299998A1 (en) 2011-03-30
DK2299998T3 (en) 2018-03-26
NZ584981A (en) 2012-05-25
BRPI0818310A2 (pt) 2017-10-10
PT2299998T (pt) 2018-04-02
IL205362A0 (en) 2010-12-30
RU2010122302A (ru) 2011-12-10
BRPI0818310A8 (pt) 2017-12-26
EP2299998A4 (en) 2011-03-30
WO2009055933A1 (en) 2009-05-07
KR20100106958A (ko) 2010-10-04
ZA201003030B (en) 2011-02-23
CN101878028A (zh) 2010-11-03

Similar Documents

Publication Publication Date Title
CA2704286C (en) Medium-chain length fatty acids and glycerides as nephroprotection agents
ES2262741T3 (es) Uso de acidos grasos poliinsaturados para la prevencion de accidentes cardiovasculares importantes.
KR101336756B1 (ko) 뇌졸중 재발 예방용 조성물
JP6267681B2 (ja) Ｃ１６：１ｎ７−パルミトレアートを含む組成物および方法
US8933255B2 (en) Nutraceuticals containing nitro fatty acids
CZ20012947A3 (cs) Pouľití esenciálních mastných kyselin pro prevenci kardiovaskulárních příhod
WO2010038796A1 (ja) Ｃ型肝炎治療剤
EA009939B1 (ru) Жирные кислоты со средней длиной цепи, глицериды и аналоги в качестве стимуляторов эритропоэза
US20230321022A1 (en) Reversibly protected thiolated electrophilic fatty acids as prodrugs
KR20100015986A (ko) 지방간 또는 비알코올성 지방성 간염의 예방 및/또는 치료를 위한 의약
HK1150125A (en) Medium-chain length fatty acids and glycerides as nephroprotection agents
CN110139645A (zh) 用于预防和/或治疗恶病质的ω-3脂肪酸组合物
Belluzzi Polyunsaturated fatty acids and autoimmune diseases
Belluzzi 16 Polyunsaturated Fatty Acids
AU2013219235B2 (en) Nutraceuticals containing nitro fatty acids

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: PROMETIC PHARMA SMT LIMITED

Free format text: FORMER OWNER WAS: PROMETIC BIOSCIENCES INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired